Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V9KF
|
|||
Former ID |
DNC005082
|
|||
Drug Name |
8-(3,3,3-trifluoropropoxy)quinolin-2-amine
|
|||
Synonyms |
CHEMBL187165; 8-(3,3,3-trifluoropropoxy)quinolin-2-amine; SCHEMBL5884488
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H11F3N2O
|
|||
Canonical SMILES |
C1=CC2=C(C(=C1)OCCC(F)(F)F)N=C(C=C2)N
|
|||
InChI |
1S/C12H11F3N2O/c13-12(14,15)6-7-18-9-3-1-2-8-4-5-10(16)17-11(8)9/h1-5H,6-7H2,(H2,16,17)
|
|||
InChIKey |
ZGZSZXFSLMTFBX-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Melanin-concentrating hormone receptor 1 (MCHR1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1. Bioorg Med Chem Lett. 2004 Oct 4;14(19):4873-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.